Abstracts of the 2022 Annual Meeting of the ALEH
Más datosLiver cirrhosis secondary to metabolic syndrome has become one of the most prevalent causes of cirrhosis and is assumed to have a prognosis similar to that of cirrhosis of other etiologies. This study aimed to describe the clinical characteristics of liver cirrhosis secondary to metabolic syndrome (MAFLD) at the Clinicas Hospital and compare it with ethyl cirrhosis (ET).
Materials and MethodsAnalytical, retrospective, cross-sectional, non-probabilistic observational study of consecutive cases. The medical records of the Gastroenterology Department of the Clinicas Hospital for the years 2018 and 2019 were reviewed and patients diagnosed with ET cirrhosis and MAFLD were recruited. For data processing, the computer programs Excel 2010, Word 2010 and the statistical programs MedCalc version 20.110, Epi dat 3.1 and IBM SPSS were used.
Results900 medical records were analyzed, 100 patients with liver cirrhosis were identified, 77 of alcoholic etiology and 23 secondary to metabolic syndrome.
ConclusionsIn the present study, liver cirrhosis secondary to MAFLD presents complications typical of cirrhosis, the incidence of hepatocarcinoma, functional status and average survival similar to those of alcoholic cirrhosis. However, elements of the metabolic syndrome are much more so in cirrhotic MAFLD than in cirrhotic ET.
Comparing both groups, the following results were obtained:
